Mesoblast Ltd (MESO) Earning Prediction
Mesoblast Ltd (MESO) is set to release its earnings performance on 07/04 ET in trading. Consensus forecasts predict a revenue of - and an earnings per share (EPS) of for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
MESO Transcript
The company's financial performance shows improvement with increased revenue, reduced net loss, and better gross margin. However, the lack of specific strategic updates, regulatory hurdles, and negative cash flow from operations are concerns. The absence of shareholder return discussions and unclear management responses in the Q&A add uncertainty. Overall, the mixed signals suggest a neutral outlook.
The earnings call presents a mixed picture: strong gross margins and positive market access developments are offset by increased expenses and non-cash losses. The Q&A reveals some uncertainty, particularly regarding sales projections and treatment kit data. The company's strategic focus on trials and market expansion is promising, but lack of specific guidance tempers enthusiasm. Given these factors, the stock price is likely to remain stable in the short term.
The earnings call indicates strong financial metrics with a reduced net operating cash spend and positive revenue expectations from RYONCIL. Despite regulatory and competitive risks, the FDA approval and positive payer feedback are promising. The absence of a shareholder return plan is a slight drawback, but the overall sentiment is positive due to the product's market potential and the company's proactive approach to launching and expanding RYONCIL.
The company's earnings call reveals mixed signals: positive developments like increased enrollment sites for trials and positive payer feedback are offset by competitive pressures and significant financial losses. The Q&A section highlights positive payer feedback and rapid enrollment plans, but unclear timelines for FDA discussions raise concerns. The lack of a shareholder return plan and financial risks such as a substantial loss after tax further moderate the outlook. Given these factors, the stock price is likely to remain stable, leading to a neutral prediction.
MESO Report
Frequently Asked Questions
What is the Mesoblast Ltd {quarter} Earnings Release Date and Time?
Mesoblast Ltd (MESO) is scheduled to release its {quarter} earnings report on Jul 4, 2024, {time} (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Mesoblast Ltd {quarter} Revenue and EPS?
Analysts' consensus predicts {revenue} in revenue and an EPS of {eps} for Mesoblast Ltd's {quarter}.
What Does Intellectia's AI Predict for Mesoblast Ltd {quarter} Earnings?
Intellectia's exclusive AI algorithms forecast a {conclusion} for Mesoblast Ltd's {quarter} earnings, with a prediction date of Jul 4, 2024. Mesoblast Ltd {summary}
How Can I Use This Earnings Prediction to Trade MESO Stock?
Leverage Intellectia's AI forecast to position trades ahead of the Jul 4, 2024 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Mesoblast Ltd {quarter}?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company's earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They're updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
